Cytokine phenotype of human autoreactive T cell clones specific for the immunodominant myelin basic protein peptide (83-99)

Journal of Neuroscience Research

Volumn 45, Issue 6, 1996, Pages 852-862

  Hemmer, B ^a   Vergelli, M ^a   Calabresi, P ^a   Huang, T ^a   McFarland, H F ^a   Martin, R ^a,b  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

cytokine; EAE; MBP; MS

Indexed keywords

CD4 ANTIGEN; CYTOKINE; EPITOPE; GAMMA INTERFERON; HLA ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; LYMPHOTOXIN; MYELIN BASIC PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANTIGEN SPECIFICITY; ARTICLE; CONTROLLED STUDY; HELPER CELL; HLA TYPING; HUMAN; HUMAN CELL; LYMPHOCYTE CLONE; LYMPHOCYTE PROLIFERATION; MULTIPLE SCLEROSIS; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE RECEPTOR GENE; T LYMPHOCYTE SUBPOPULATION;

EID: 0029743819     PISSN: 03604012     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4547(19960915)45:6<852::AID-JNR22>3.0.CO;2-W     Document Type: Article

References (42)

1. Allegretta M, Albertini RJ, Howell MD, Smith LR, Martin R, McFarland HF, Sriram S, Brostoff SW, Steinman L (1994): Homologies between T cell receptor junctional sequences unique to multiple sclerosis and T cells mediating experimental allergic encephalomyelitis. J Clin Invest 94:105-109.
2. Ando DG, Clayton J, Kono D, Urban JL, Sercarz EE (1989): Encephalitogenic T cells in the B10.PL model of experimental allergic encephalomyelitis (EAE) are of the Th-1 lymphokine subtype. Cell Immunol 124:132-143.
3. Brocke S, Gijbels K, Allegretta M, Ferber I, Piercy C, Blankenstein T, Martin R, Utz U, Karin N, Mitchell D, Veromaa T, Fairchild PJ, Wraith DC, O'Garra A, Fathman CG, Steinman L (1996): Dynamics of autoimmune T cell infiltration: Reversal of paralysis and disappearance of inflammation following treatment of experimental encephalomyelitis with a myelin basic protein peptide analog. Nature 379:343-346.
4. Cannella B, Raine CS (1995): The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann Neurol 37:424-435.
5. Correale J, Gilmore W, McMillan M, Li S, McCarthy K, Le T, Weiner LP (1995): Patterns of cytokine secretion by autoreactive proteolipid protein-specific T cell clones during the course of multiple sclerosis. J Immunol 154:2959-2968.
6. Deibler GE, Martenson RE, Kies MW (1972): Large scale preparation of myelin basic protein from central nervous system tissue of several mammalian species. Prep Biochem 2:139-165.
7. Del Prete G, De Carli M, Almerigogna F, Giudizi MG, Biagiotti R, Romagnani S (1993): Human IL-10 is produced by both type 1 helper (Th1) and type 2 helper (Th2) T cell clones and inhibits their antigen-specific proliferation and cytokine production. J Immunol 150:353-361.
8. Farrar MA, Schreiber RD (1993): The molecular cell biology of interferon-γ and its receptor. Annu Rev Immunol 11:571-612.
9. Firestein GS, Roeder WD, Laxer JA, Townsend KS, Weaver CT, Hom JT et al. (1989): A new murine CD4+ T cell subset with an unrestricted cytokine profile. J Immunol 143:518-525.
10. Fritz RB, McFarlin DE (1989): Encephalitogenic epitopes of myelin basic protein. In Sercarz EE (ed): "Antigenic Determinants and Immune Response." Chem Immunol 46. Basel: Karger, 46: 101-125.
11. Heinzel FP, Sadick MD, Holaday BJ, Coffmann RL, Locksley RM (1989): Reciprocal expression of interferon-γ and IL-4 during the resolution of progression of murine leishmaniasis: Evidence for expansion of distinct helper T cell subsets. J Exp Med 169:59-72.
12. Jaraquemada D, Martin R, Rosen-Bronson S, Flerlage M, McFarland HF, Long EO (1990). HLA-DR2a is the dominant restriction molecule for the cytotoxic T cell response to myelin basic protein in DR2Dw2 individuals. J Immunol 145:2880-2885.
13. Janeway CA, Bottomly K (1994): Signals and Signs for lymphocyte responses. Cell 76:275-285.
14. Karpus WJ, Gould KE, Swanborg RH (1992): CD4+ suppressor cells of autoimmune encephalomyelitis respond to T cell receptor-associated determinants on effector cells by interleukin-4 secretion. Eur J Immunol 22:1757-1763.
15. Karpus WJ, Swanborg RH (1991): CD4+ suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-β1. J Immunol 146:1163-1168.
16. Kelso A (1995). Th1 and Th2 subsets: Paradigms lost? Immunol Today 16:374-379.
17. Kelso A, Groves P, Troutt AB, Francis K (1995). Evidence for the stochastic acquisition of cytokine profile by CD4+ T cells activated in a T helper type 2-like response in vivo. Eur J Immunol 25:1168-1175.
18. Ling N, Esch F, Böhlen P, Brazeau P, Wehrenberg WB, Guillemin R (1984): Isoation, primary structure, and synthesis of human hypothalamic somatocrinin: Growth hormone-releasing factor. Proc Natl Acad Sci U S A 81:4302-4306.
19. Martin R, Howell MD, Jaraquemada D, Flerlage M, Richert J, Brostoff S et al. (1991): A myelin basic protein peptide is recognized by cytotoxic T cells in the context of four HLA-DR types associated with multiple sclerosis. J Exp Med 173:19-24.
20. Martin R, McFarland HF, McFarlin DE (1992a): Immunological aspects of demyelinating diseases. Annu Rev Immunol 10:153-187.
21. Martin R, Utz U, Coligan JE, Richert JR, Flerlage M, Robinson E et al. (1992b): Diversity in fine specificity and T cell receptor usage of the human CD4+ cytotoxic T cell response specific for the immunodominant myelin basic protein peptide 87-106. J Immunol 148:1359-1366.
22. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffmann RL (1986): Two types of murine helper T cell clones: I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136:2348-2357.
23. Mosmann TR, Coffmann RL (1989): Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol 7:145-173.
24. Mosmann TR, Sad S (1996): The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146.
25. Oksenberg JR, Panzara MA, Begovich AB, Mitchell D, Erlich HA, Murray RS et al. (1993): Selection for T-cell receptor Vβ-Dβ-Jβ gene rearrangements with specificity for a myelin basic protein peptide in brain lesions of multiple sclerosis. Nature 362:68-70.
26. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA (1990): T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 346:183-187.
27. Panitch HS, Hirsch RL, Schindler J, Johnson KP (1987): Treatment of multiple sclerosis with gamma interferon: Exacerbations associated with activation of the immune system. Neurology 37: 1097-1102.
28. Paul WE, Seder RA (1994): Lymphocyte responses and cytokines. Cell 76:241-251.
29. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G et al. (1990): Myelin autoreactivity in multiple sclerosis: Recognition of myelin basic protein in the context of HLA-DR2 products by T lymphocytes of multiple sclerosis patients and healthy donors. Proc Natl Acad Sci U S A 87:7968-7972.
30. Powell MB, Mitchell D, Lederman J, Buckmeier J, Zamvil SS, Graham M et al. (1990): Lymphotoxin and tumor necrosis factor-alpha production by myelin basic protein-specific T cell clones correlates with encephalitogenecity. Int Immunol 2:539-543.
31. Racke MK, Bonomo A, Scott DE, Cannella B, Levine A, Raine CS et al. (1994): Cytokine-induced immune deviation as a therapy for inflammatory autoimmune disease. J Exp Med 180:1961-1966.
32. Racke MK, Burnett D, Pak S-H, Albert PS, Cannella B, Raine CS et al. (1995): Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450-458.
33. Romagnani S (1994): Lymphokine production by human T cells in disease states. Annu Rev Immunol 12:227-257.
34. Richert J, Robinson ED, Deibler GE, Martenson RE, Dragovic LJ, Kies MW (1989). Evidence for multiple human T cell recognition sites on myelin basic protein. J Neuroimmunol 23:55-66.
35. Ruddle NH, Bergman CM, McGrath KM, Lingenheld EG, Grunnet ML, Padula SJ et al. (1990): An antibody to lymphotoxin and tumor necrosis factor prevents transfer of experimental allergic encephalomyelitis. J Exp Med 172:1193-200.
36. Sharief MK, Hentges R (1991): Association between tumor necrosis factor-a and disease progression in chronic progressive multiple sclerosis. N Engl J Med 325:467-472.
37. Sher A, Coffman RL (1992): Regulation of immunity to parasites by T cells and T cell-derived cytokines. Ann Rev Immunol 10: 385-409.
38. Vassalli P (1992): The pathophysiology of tumor necrosis factors. Annu Rev Immunol 10:411-452.
39. Voskuhl RR, Martin R, Bergman C, Dalal M, Ruddle NH, McFarland HF (1993): T helper 1 (TH1) functional phenotype of human myelin basic protein-specific T lymphocytes. Autoimmunity 15:137-143.
40. Yssel H, de Waal Malefijt R, Roncarolo MG, Abrams JS, Lahesmaa R, Spits H et al. (1992): IL-10 is produced by subsets of human CD4+ T cell clones and peripheral blood T cells. J Immunol 149:2378-2384.
41. Zamvil SS, Steinman L (1990): The T lymphocyte in experimental allergic encephalomyelitis. Annu Rev Immunol 8:579-621.
42. Zhang J, Markovic-Plese S, Lacet B, Raus J, Weiner HL, Hafler DA (1994): Increased frequency of interleukin 2-responsive T cells specific for myelin basic protein in peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. J Exp Med 179:973-984.